Effect of thyroid hormone on gastric mucus secretion around indomethacin induced gastric ulcers in rats

Journal of Medical Sciences

Volumn 7, Issue 4, 2007, Pages 678-681

  Oluwole, F S ^a   Saka, M T ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Adherent gastric mucus; Misoprostol; Thyroxine; Ulceration

Indexed keywords

GLYCOPROTEIN; INDOMETACIN; MISOPROSTOL; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALE; MUCUS SECRETION; NONHUMAN; RAT; SCORING SYSTEM; STOMACH MUCUS; STOMACH PROTECTION; STOMACH ULCER;

EID: 34250901800     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2007.678.681     Document Type: Article

References (16)

1. Adeniyi, K.O. and M.O. Olowokorun, 1986. Gastric acid secretion and parietal cell mass, effect of thyroidectomy and thyroxine. Am. J. Physiol., 256: G975-978.
2. Adeniyi, K.O. and F.S. Oluwole, 1990. Influence of thyroid hormones on indomethacin-induced gastric ulceration in rats. Nig. J. Physiol. Sci., 6: 192-196.
3. Allen, A., 1981. Structure and Function of Gastrointestinal Mucus. In: Physiology of the Gastrointestinal Tract. Johnson, L.R. (Ed.), New York, Raven Press, pp: 617-639.
4. Alphin, R.S. and J.W. Ward, 1967. Actions of hexapyronium bromide on gastric secretion in dogs and ulceration in rats. Arch. Intl. De Pharmacodyn. Therap., 168: 82-100.
5. Azzumi, Y., T. Ichikawa, K. Ishihara and K. Hotta, 1993. The validity of the ethanol precipitation method for the measurement of mucin content in human gastric juices and its relationship to gastroduodenal disease. Clin. Chim. Acta., 221: 219-225.
6. 2, carbolpolyacrylate, sucrafate and bismuth salicylate. J. Gastroenterol. Hepatol., 9: S55-59.
7. Corne, S.J., S.M. Morrissey and R.J. Wood, 1974. A method for the quantitative estimation of gastric barrier mucus. J. Physiol. London, pp: 116-117.
8. Cross, C.E., B. Halliwell and A. Allen, 1984. Antioxidant protection: A function of tracheobronchial and gastrointestinal mucus. Lancet, 1: 328-330.
9. Dajani, E.Z., 1987. Overview of the mucosal protective effects of misoprostol in man. Prostaglandins, 33: 117-129.
10. Gong, D.H., B. Turner, K.R. Bhaskar and J.T. Lamont, 1990. Lipid binding to gastric mucin: Protective effect against oxygen radicals. Am. J. Physiol., 259: G681-686
11. Hawkey, C.J., 1996. Non-steroidal anti-inflammatory drug gastropathy: Causes and treatment. Scand J. Gastroenterol. Suppl., 220: 124-127.
12. Hodin, R.A., A. Shei and M. Mengs, 1996. Thyroid hormone and the gut: Selective transcriptional activation of a villus-enterocyte marker. Surgery, 120: 138-143.
13. 2. Gastroentero. Clin. Biol., 18: 609-616.
14. Simon, L.S., 1999. The evolution of arthritis antiinflammatory care: Where are we today? J. Rheumatol., 26(suppl)56: 11-17.
15. Takezono, Y., T. Joh, T. Oshima and H. Suzuki et al., 2004. Role of prostaglandins in maintaining gastric mucus cell permeability against acid exposure. J. Lab. Clin. Med., 143: 52-58.
16. Wilson, D.E., E. Quadros, T. Rajapaksa, A. Adams and M. Noar, 1986. Effects of misoprostol on gastric acid and mucus secretion in man. Dig. Dis. Sci., 31 (suppl 2): 126s-129s.